Calley Means: How Big Food And Big Pharma Blocked Popular MAHA Reforms

In a far-ranging interview with Joe Rogan, former White House adviser Calley Means described a web of lobbyists manipulating policy decisions behind the scenes.

Abdul El-Sayed Taps Former Big Pharma Lobbyist To Lead Senate Transition After Campaigning as a Crusader Against Big Pharma: Pick Is Fiercely Anti-Israel

Michigan senator-elect Abdul El-Sayed, who ran as a crusader against Big Pharma during his campaign and falsely accused his Republican opponent of being a lobbyist for the industry, has tapped a former Big Pharma lobbyist to run his Senate transition team, the Washington Free Beacon found.

The post Abdul El-Sayed Taps Former Big Pharma Lobbyist To Lead Senate Transition After Campaigning as a Crusader Against Big Pharma: Pick Is Fiercely Anti-Israel appeared first on .

FDA, NYT Downplayed Evidence Showing Covid Shots May Have Killed Kids

The pharmaceutical industry was intent on protecting its profits, and influential media outlets have downplayed evidence of Covid vaccine deaths and attack those who’ve tried to bring them to light.

Troy Jackson, Who Called Big Pharma 'the Anti-Christ,' Spotted Campaigning With Lobbyists Who Repped Pharma Company That Jacked Up Price of Cystic Fibrosis Drug

Maine Democratic Senate hopeful Troy Jackson has referred to the pharmaceutical industry as "the anti-Christ" and attacked "high-priced lobbyists and corporate greed." He also appears to have a close relationship with a pair of Maine lobbyists who represented a pharmaceutical company that faced intense criticism for jacking up the price of its cystic fibrosis drug.

The post Troy Jackson, Who Called Big Pharma 'the Anti-Christ,' Spotted Campaigning With Lobbyists Who Repped Pharma Company That Jacked Up Price of Cystic Fibrosis Drug appeared first on .

Why Eric Cantor Going To Head Big Pharma Is The Swampiest Move Ever

Eric Cantor will become the next head of PhRMA, and the two seem made for each other for all the wrong reasons.

The drug you keep seeing at vape shops has a dark side



Kratom products are advertised everywhere — at gas stations, smoke shops, and vape stores — but comedian and filmmaker Davey Jackson believes the rapidly growing industry deserves far more scrutiny.

In a new documentary, Jackson examines how concentrated kratom extracts and synthetic derivatives have transformed a once-obscure plant into a multibillion-dollar industry.

“There’s basically three categories. There’s natural powder leaf kratom, which a lot of people use and have used successfully for, you know, a lot of years. And then there’s a slightly newer product, and it’s an extract,” Jackson tells BlazeTV host Sara Gonzales.

“So they’re basically extracting and concentrating the kratom into these drinks ... which that’s a whole other story. And then they have these synthetic products like 7-OH or MGM-15 or MGM-16 that the DEA is in the process of banning right now,” he explains.


Gonzales points out that “there’s big money in the industry,” referencing the company Feel Free.

“That’s an interesting one. So they got their start giving away their products on college campuses, just handing them out to college students. And again, this is a fairly addictive thing that we’re dealing with here,” Jackson says.

“These Feel Free shots, you know, they’re not as bad as the 7-OH tablets that are getting banned right now, but they’re certainly habit-forming. Much more potent than the actual kratom product,” he explains, noting that the founder of Feel Free is “an ex-con” who “spent time in federal prison for fraud.”

“They’re the number one retail kratom product in America. I want to say they’re doing $250 million a year in sales. They’ve been investigated by the DOJ ... and they actually are a big part of the kratom conspiracy that we were investigating,” he continues.

“It just must all come down to money, right? Whoever is making money wants to keep it alive,” Gonzales says.

“Yeah,” Jackson agrees. “So you’ve got companies like Feel Free who absolutely want to keep it alive and have lobbied to keep the kratom industry unregulated to a large extent, but they were also a big part of the push behind the ban for 7-OH because 7-OH was, you know, kind of taking up market share.”

“They’re making $250 million a year already, but obviously they want to make more. And then of course, there’s Big Pharma. You know, people that are taking 7-OH that you can buy at a gas station or a smoke shop,” he continues.

“Granted,” he adds, “I don’t think it’s safe from a regulatory perspective as far as what they’re actually putting in this stuff because I’ve heard multiple times there’s 7-OH that’s been tested that has [fentanyl] in it. I mean, that’s horribly dangerous, right?”

Want more from Sara Gonzales?

To enjoy more of Sara's no-holds-barred takes on news and culture, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution, and live the American dream.

Parents, not bureaucrats, should call the shots



President Trump signed an executive order last week reducing the number of recommended childhood vaccines from 18 to 11 and urging states with school-entry requirements to update their laws accordingly.

That should be a starting point, not an end point.

More coercion will deepen skepticism, not cure it.

Alabama is already closer to that model than most states. Its school-entry requirements rely on a narrower set of core vaccines and do not force hepatitis B vaccination for every student. Other states should treat the president’s order as the floor for vaccine freedom, not the ceiling.

The most immediate step is obvious: States can reduce school-entry requirements to match the new federal recommendations. Better still, they should eliminate those mandates altogether or, at minimum, make it much easier for families to opt out.

Coercion has no place in parental medical decisions. Public schools exist to teach reading, writing, and arithmetic. They should not condition access to a publicly funded classroom on a government-approved medical regimen.

Aligning state rules with the new federal baseline would be progress. But true parental authority requires going farther.

Forty-six states already allow religious exemptions from school vaccine requirements. Their broad existence also shows that states can preserve opt-outs without schools simply ceasing to function.

Religious exemptions should remain. But the principle should not end there.

Parents can have sincere nonreligious reasons for declining particular vaccines, whether because of personal medical history, concerns about a specific product, or objections to the schedule itself. Treating religious objections as legitimate while dismissing every other conscientious objection draws an arbitrary line.

States should therefore expand personal and philosophical exemptions as well. Families should not have to choose between access to public education and surrendering authority over their children’s medical decisions.

Idaho has already gone farther. Its Medical Freedom Act prohibits schools from imposing medical intervention mandates, including vaccine requirements, as a condition of attendance. Florida Surgeon General Joseph Ladapo is pushing in the same direction, seeking to eliminate school vaccine mandates entirely in the Sunshine State.

Other lawmakers should study those models. The core principle is straightforward: Attending a government school should not require surrendering parental authority over a child’s body.

The burden of vaccine mandates also falls unevenly.

Affluent parents who object can more easily homeschool or move a child to a private school with different policies. Working families often have fewer options. They may be forced to comply, navigate exemption processes that demand time and paperwork they do not have, or keep a child out of the classroom.

RELATED: Fauci is yesterday’s fight. Medical freedom is today’s.

Adam Glanzman/Bloomberg/Getty Images

That creates a two-tier system in which families with the fewest resources have the least room to exercise meaningful choice.

Reducing mandates or broadening opt-outs would expand educational freedom precisely for the families who are most constrained by the current system.

None of this prevents families from vaccinating their children. Parents who want the full schedule remain free to choose it. The question is whether the state should force that choice on everyone else as the price of attending school.

Public trust in health institutions fell sharply after COVID. Rebuilding that trust will require transparent information, honest risk communication, and genuine freedom to say no. More coercion will deepen skepticism, not cure it.

President Trump’s executive order gives states a practical starting point.

Legislatures should use it: Reduce school-entry vaccine mandates to the new federal baseline, expand opt-outs beyond religious grounds, or eliminate the mandates entirely.

Parents, not bureaucrats, should decide what goes into their children’s bodies. States that move first can expand educational freedom while beginning the harder work of rebuilding public confidence through voluntary cooperation rather than compulsion.

Why The Trump Administration Was Right To End The Medicare Part D Insurer Bailout

The temporary and extralegal bailout that provided billions of dollars in subsidies to insurers cost the program far more than Dems claimed.

How Obamacare Pushes Big Pharma To Overcharge You For Prescriptions

I found out firsthand: big conglomerates make profits by keeping the system complicated, bureaucratic, and opaque.

Trump hits foreign drug manufacturers in HUGE announcement



The cost of generic drugs will likely change drastically after the latest tariff announcement from President Donald Trump.

The president said in a post on Truth Social that he would allow generic drug imports to have zero tariffs for two years, then face two large hikes afterward.

'The objective of this Policy is to protect the people of the United States.'

Trump said the tariffs were designed to encourage drug companies to move their manufacturing operations back to the U.S.

"Effective August 1st, 2026, all Generic Drugs being brought into the United States will continue to have a TARIFF of ZERO PERCENT for a two year period of time, after which the TARIFF will be raised to 100% for a one year period of time, and 200% thereafter," he wrote.

"The objective of this Policy is to protect the people of the United States," Trump added.

Generic drugs account for 90% of the prescriptions in the U.S., according to the Food and Drug Administration, and half of generic drugs are manufactured in India. China, on the other hand, is the source for 95% of imported ibuprofen and 70% of imported acetaminophen.

White House spokesman Kush Desai cited other efforts from the administration to reshore manufacturing in comments to CBS News.

"The President's resounding success securing firm reshoring plans from global drugmakers as part of our most-favored-nations deals and Section 232 tariff program for branded drugs is proof that this administration has a track record of success to get critical manufacturing back into the United States," Desai said in an email.

RELATED: The hidden danger in Trump’s drug-price plan

Experts indicated to CBS News that manufacturers were likely to pass on the tariff costs to consumers but that the already low prices meant the cost increases could be modest.

However, some manufacturers may choose to pull out of the U.S. market altogether and cause drug shortages.

"Pharmaceutical Facilities are being built, at a level never seen before, all over the United States of America. Thank you for your attention to this matter!" Trump concluded.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!